Physician profile
Corinna Deeter
NPI 1356976609
$943.56
in general payments reported to CMS, 2019-2025
16 companies · $34.04 in 2025
The $34.04 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $897 · 2022: $12.34 · 2025: $34.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $216.14 | 2021 | |
| Abbvie INC. | $189.62 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $117.49 | 2021 | |
| Amarin Pharma, INC. | $77.13 | 2021 | |
| Novo Nordisk INC | $71.49 | 2021 | |
| Astellas Pharma US INC | $47.31 | 2021 | |
| Pfizer INC. | $40.97 | 2021 | |
| Lilly USA, LLC | $35.77 | 2021 | |
| Dexcom, INC. | $27.53 | 2021 | |
| Sunovion Pharmaceuticals INC. | $26.66 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.40 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.01 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.49 | 2021 | |
| Amgen INC. | $13.47 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinna Deeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.